
Search
Filter Results
Displaying 481–490 of 689 for “retinitis clinical trial”
-
Sep 20, 2024
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
Dr. Zuhal Butuner talks about her company’s two emerging RNA therapies for LCA10 and USH2A.
-
Sep 18, 2024
Innovative Ways to Support Research for Treatments and Cures for Blinding Diseases
-
Aug 9, 2024
Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
Dr. Saad discusses an emerging therapy for Stargardt disease that has performed well in clinical trials.
-
Jul 12, 2024
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
Francois Paquet-Durand, PhD, a professor from the University of Tübingen and co-founder of the company Mireca, talks to host Ben Shaberman about the long journey of an emerging, Foundation-funded drug for the treatment of certain forms of retinitis pigmentosa. The episode highlights the challenges that scientists often encounter when developing a drug for a retinal disease, and the persistence and tenacity that are required to keep it moving forward.
-
Jun 27, 2024
Karen Petrou Appointed as Board Chair of the Foundation Fighting Blindness
David Brint retires after eight years of distinguished service; Petrou to lead effective July 1, 2024.
-
May 22, 2024
Advancing Research Solutions for PRPH2-Associated Retinal Diseases.
-
Foundation Fighting Blindness Clinical Consortium
The Foundation Fighting Blindness Clinical Consortium is a not-for-profit alliance of retinal disease specialists and geneticists committed to accelerating development of efficacious treatments for inherited retinal diseases (IRDs).
-
Apr 8, 2024
What Does “Blindness” Really Mean?
Jenny Schisler has retinitis pigmentosa. Jenny wants to spread awareness of what having a visual impairment really means to her and others affected by retinal degenerative diseases.
-
Feb 13, 2024
The free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Feb 2, 2024
Eye on the Cure Podcast | Episode 61: Dr. Jose Sahel
Dr. Jose Sahel, one of the most honored and accomplished leaders in the retinal disease research space, talks with host Ben Shaberman about his establishment and leadership of renowned ophthalmology clinical research centers at the University of Pittsburgh Medical Center and Institut de la Vision in Paris. They also discuss emerging inherited retinal disease therapies from SparingVision, a biotech co-founded by Dr. Sahel.